Drug interactions
Capecitabine + Idecabtagene vicleucel
Severity: Major
Capecitabine and Idecabtagene vicleucel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Capecitabine causes myelosuppression and lymphopenia, which can add to the prolonged cytopenias and infection risk seen after CAR-T therapy. Chemotherapy given around the time of cell infusion may also impair CAR-T expansion and persistence.
What this interaction means in plain words
Capecitabine and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Capecitabine belongs to Oncology; Idecabtagene vicleucel belongs to Oncology.
Why it happens
Additive myelosuppressive and immunosuppressive effects, with possible cytotoxic effects on infused T cells.
What to do
Avoid capecitabine during lymphodepletion and the early period after CAR-T infusion unless clearly required. If used, monitor blood counts and infection signs closely and give anti-infective prophylaxis as per protocol.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Capecitabine and Idecabtagene vicleucel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Capecitabine
Other interactions of Idecabtagene vicleucel
Frequently asked questions
Can I take Capecitabine with Idecabtagene vicleucel?
MediHelp rates the interaction as major. Capecitabine and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Capecitabine causes myelosuppression and lymphopenia, which can add to the prolonged cytopenias and infection risk seen after CAR-T therapy. Chemotherapy given around the time of cell infusion may also impair CAR-T expansion and persistence.
How serious is the interaction between Capecitabine and Idecabtagene vicleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid capecitabine during lymphodepletion and the early period after CAR-T infusion unless clearly required. If used, monitor blood counts and infection signs closely and give anti-infective prophylaxis as per protocol.
What other medicines interact with Capecitabine?
MediHelp also lists interactions of Capecitabine with, for example, Adenovirus types 4 and 7 live, Arsenic trioxide, Axicabtagene ciloleucel. The full list is on the Capecitabine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
